JP2023517035A - 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 - Google Patents
間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 Download PDFInfo
- Publication number
- JP2023517035A JP2023517035A JP2022553155A JP2022553155A JP2023517035A JP 2023517035 A JP2023517035 A JP 2023517035A JP 2022553155 A JP2022553155 A JP 2022553155A JP 2022553155 A JP2022553155 A JP 2022553155A JP 2023517035 A JP2023517035 A JP 2023517035A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- subject
- stem cells
- mlpscs
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900685 | 2020-03-05 | ||
| AU2020900685A AU2020900685A0 (en) | 2020-03-05 | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells | |
| PCT/EP2021/055483 WO2021176001A1 (en) | 2020-03-05 | 2021-03-04 | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517035A true JP2023517035A (ja) | 2023-04-21 |
| JP2023517035A5 JP2023517035A5 (cg-RX-API-DMAC7.html) | 2024-03-13 |
Family
ID=74867509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022553155A Pending JP2023517035A (ja) | 2020-03-05 | 2021-03-04 | 間葉系統前駆または幹細胞を使用して炎症性肺疾患を治療するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12697355B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4114418B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023517035A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220150919A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115361958A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021232614A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022017557A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3170255A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021176001A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012048093A2 (en) | 2010-10-08 | 2012-04-12 | Osiris Therapeutics, Inc. | Enhanced msc preparations |
| WO2019102268A1 (en) | 2017-11-22 | 2019-05-31 | Mesoblast International Sarl | Cellular compositions and methods of treatment i |
| US12702683B2 (en) | 2019-01-03 | 2026-08-11 | Mesoblast International Sárl | Method for improving visual acuity |
| WO2021176001A1 (en) | 2020-03-05 | 2021-09-10 | Mesoblast International Sàrl | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
| EP4181935A1 (en) * | 2020-07-20 | 2023-05-24 | Brainstorm Cell Therapeutics Ltd. | Methods and compositions for treating lung conditions |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120087933A1 (en) * | 2010-10-08 | 2012-04-12 | Samson Tom | Enhanced msc preparations |
| WO2015016761A2 (en) * | 2013-08-01 | 2015-02-05 | Isletone Ab | Mscs in the treatment of inflammatory pulmonary diseases |
| WO2018151046A1 (ja) * | 2017-02-15 | 2018-08-23 | ロート製薬株式会社 | 肺線維症治療剤、ptprr発現促進剤及び肺線維症治療用キット |
| WO2019051623A1 (es) * | 2017-09-16 | 2019-03-21 | Cells For Cells S.A. | Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US6974571B2 (en) | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
| US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| US20030103951A1 (en) | 1997-07-14 | 2003-06-05 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| WO1999003973A1 (en) | 1997-07-14 | 1999-01-28 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| DE69922933T2 (de) | 1998-03-13 | 2005-12-29 | Osiris Therapeutics, Inc. | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
| WO1999047163A2 (en) | 1998-03-18 | 1999-09-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| US6368636B1 (en) | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| US20030118567A1 (en) | 1999-03-26 | 2003-06-26 | Stewart Duncan John | Cell-based therapy for the pulmonary system |
| WO1999051247A1 (en) | 1998-04-03 | 1999-10-14 | Osiris Therapeutics, Inc. | Use of human mesenchymal stem cells to induce t-cell apoptosis |
| JP2002510655A (ja) | 1998-04-03 | 2002-04-09 | オシリス セラピューティクス,インコーポレイテッド | 免疫抑制剤としての間葉幹細胞によるt細胞応答を阻害する方法とその利用 |
| US6030836A (en) | 1998-06-08 | 2000-02-29 | Osiris Therapeutics, Inc. | Vitro maintenance of hematopoietic stem cells |
| US8147824B2 (en) | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| AU7611500A (en) | 1999-09-24 | 2001-04-24 | Abt Holding Company | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| US6685936B2 (en) | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
| US6936281B2 (en) | 2001-03-21 | 2005-08-30 | University Of South Florida | Human mesenchymal progenitor cell |
| US20030104997A1 (en) | 2001-09-05 | 2003-06-05 | Black Ira B. | Multi-lineage directed induction of bone marrow stromal cell differentiation |
| US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
| US7628988B2 (en) | 2002-06-27 | 2009-12-08 | The General Hospital Corporation | Methods and compositions for treating type 1 diabetes |
| EP1551955A4 (en) | 2002-07-16 | 2006-11-29 | Yissum Res Dev Co | METHOD FOR IMPLANTING MESENCHYMAL STEM CELLS FOR TISSUE PAIRING AND FORMATION |
| WO2004009767A2 (en) | 2002-07-23 | 2004-01-29 | Boston Scientific Limited | Cell therapy for regeneration |
| US20060210544A1 (en) | 2003-06-27 | 2006-09-21 | Renomedix Institute, Inc. | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| CA2564679C (en) | 2004-03-22 | 2015-06-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| ES2385450T3 (es) | 2004-03-22 | 2012-07-25 | Osiris Therapeutics, Inc. | Células madre mesenquimatosas y sus utilizaciones |
| JP5162756B2 (ja) | 2005-04-14 | 2013-03-13 | 財団法人ヒューマンサイエンス振興財団 | 医薬組成物及びその製造方法 |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| US20070253931A1 (en) | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
| CN101370930A (zh) | 2006-01-13 | 2009-02-18 | 奥西里斯治疗公司 | 表达TNF-α受体的间充质干细胞 |
| EP2057195A4 (en) | 2006-08-29 | 2010-05-12 | Forhumantech Co Ltd | PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME |
| US20120269774A1 (en) | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
| EP2578677A1 (en) | 2007-08-09 | 2013-04-10 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
| KR101039235B1 (ko) | 2007-08-29 | 2011-06-07 | 메디포스트(주) | 제대혈 유래 간엽줄기세포를 포함하는 인터루킨-8 또는지알오-알파 발현 세포가 관련된 질병의 진단, 예방 또는치료용 조성물 |
| KR101995016B1 (ko) | 2007-12-04 | 2019-06-28 | 프로테오바이오엑티브스 피티와이 엘티디 | 전구 세포의 보호 및 그의 분화 조절 |
| WO2009154840A2 (en) | 2008-03-27 | 2009-12-23 | Neostem, Inc. | Compositions and methods using stem cells in cutaneous wound healing |
| MX2011001730A (es) | 2008-08-14 | 2011-03-24 | Osiris Therapeutics Inc | Composiciones purificadas de celulas madre mesenquimales y metodos para purificar composiciones de celulas madre mesenquimales. |
| WO2011047345A2 (en) | 2009-10-15 | 2011-04-21 | Tai June Yoo | Methods of treating diseases of conditions using mesenchymal stem cells |
| KR101871472B1 (ko) | 2010-07-02 | 2018-06-27 | 메소블라스트, 아이엔씨. | 이식편대숙주 질환의 치료 방법 |
| CA2809272A1 (en) | 2010-08-31 | 2012-03-08 | Cook General Biotechnology Llc | Systemic, allogenic stem cell therapies for treatment of diseases in animals |
| EP2714057B1 (en) | 2011-06-03 | 2019-11-06 | Mesoblast, Inc. | Methods of treating or preventing neurological diseases |
| US20140134140A1 (en) | 2012-11-09 | 2014-05-15 | Case Western Reserve University | Mesenchymal stem cell compositions for the treatment of microbial infections |
| JP6173157B2 (ja) | 2013-10-02 | 2017-08-02 | 日本製薬株式会社 | Il−17産生抑制組成物 |
| WO2015061839A1 (en) | 2013-11-04 | 2015-05-07 | Sturm Marian June | Cell culture method |
| CN114317461A (zh) | 2013-11-22 | 2022-04-12 | 德那翠丝有限公司 | 表达免疫细胞刺激受体激动剂的腺病毒 |
| KR102577698B1 (ko) | 2014-04-07 | 2023-09-12 | 메조블라스트 인터내셔널 에스에이알엘 | 개선된 줄기 세포 조성물 |
| WO2015189063A1 (en) | 2014-06-10 | 2015-12-17 | Mesoblast International Sàrl | Treatment of immune disorders |
| WO2016086020A1 (en) | 2014-11-24 | 2016-06-02 | Cytostormrx Llc | Encapsulated stem cells for the treatment of inflammatory disease |
| CN107206027A (zh) | 2014-12-23 | 2017-09-26 | 迈索布拉斯特国际有限公司 | 进行性心力衰竭的预防 |
| CN105796598A (zh) | 2014-12-29 | 2016-07-27 | 西比曼生物科技(上海)有限公司 | 一种用于治疗慢性阻塞性肺疾病的脂肪间充质祖细胞复合物 |
| US20180037867A1 (en) | 2015-03-04 | 2018-02-08 | Mesoblast International Sàrl | Cell culture method for mesenchymal stem cells |
| AU2016258980B2 (en) | 2015-05-05 | 2022-02-17 | Mesoblast International Sàrl | Potency assay |
| EP3619294A1 (en) | 2017-05-04 | 2020-03-11 | Mesoblast International Sàrl | Mesenchymal lineage precursor or stem cells with enhanced immunosuppression |
| WO2019102268A1 (en) | 2017-11-22 | 2019-05-31 | Mesoblast International Sarl | Cellular compositions and methods of treatment i |
| EP4772245A3 (en) | 2019-01-02 | 2026-08-19 | Mesoblast International Sàrl | Method for treating lower back pain |
| US12702683B2 (en) | 2019-01-03 | 2026-08-11 | Mesoblast International Sárl | Method for improving visual acuity |
| US20220160776A1 (en) | 2019-01-28 | 2022-05-26 | Mesoblast International Sárl | Method for treating or preventing gastrointestinal bleeding |
| CN113853206A (zh) | 2019-05-23 | 2021-12-28 | 迈索布拉斯特国际有限公司 | 脑梗塞的功能恢复 |
| EP3994245A1 (en) | 2019-07-05 | 2022-05-11 | Case Western Reserve University | Priming media and methods for stem cell culture and therapy |
| KR20220038485A (ko) | 2019-08-05 | 2022-03-28 | 메조블라스트 인터내셔널 에스에이알엘 | 바이러스 벡터를 포함하는 세포 조성물 및 치료 방법 |
| KR20220143092A (ko) | 2020-02-19 | 2022-10-24 | 메조블라스트 인터내셔널 에스에이알엘 | 만성 이식편 대 숙주 질환의 치료 방법 |
| CN111297899A (zh) * | 2020-02-21 | 2020-06-19 | 云南雅盛医疗科技有限公司 | 一种脐带间充质干细胞在制备治疗新型冠状肺炎药物中的应用 |
| WO2021176001A1 (en) | 2020-03-05 | 2021-09-10 | Mesoblast International Sàrl | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
| CN115297875A (zh) | 2020-03-11 | 2022-11-04 | 迈索布拉斯特国际有限公司 | 治疗炎症性肠病的方法ii |
| BR112022017560A2 (pt) | 2020-03-11 | 2022-12-27 | Mesoblast Int Sarl | Método para tratar doença inflamatória intestinal i |
| JP2023520233A (ja) | 2020-04-03 | 2023-05-16 | メゾブラスト・インターナショナル・エスアーエールエル | 間葉系統前駆細胞又は幹細胞を使用する過炎症の治療方法 |
| JP2023524660A (ja) | 2020-04-28 | 2023-06-13 | ファクター バイオサイエンス インコーポレイテッド | 間葉系幹細胞療法 |
| CA3181611A1 (en) | 2020-06-11 | 2021-12-16 | Paul Simmons | 3d culture of mesenchymal lineage precursor or stem cells |
| US20230398154A1 (en) | 2020-08-10 | 2023-12-14 | Mesoblast International Sárl | A composition comprising mesenchymal precursor or stem cells and their use |
| CN115996735A (zh) | 2020-08-10 | 2023-04-21 | 迈索布拉斯特国际有限公司 | 细胞组合物和治疗方法 |
| WO2022132986A2 (en) | 2020-12-15 | 2022-06-23 | Mesoblast International Sarl | Method of treating progressive heart failure in subjects with class ii heart failure |
| CN112522191B (zh) | 2020-12-18 | 2023-05-12 | 云南中科灵长类生物医学重点实验室 | 一种间充质干细胞的培养方法 |
| AU2022210364A1 (en) | 2021-01-22 | 2023-08-31 | Mesoblast International Sàrl | Opioid sparing compositions and methods of using the same |
| BR112023021840A2 (pt) | 2021-04-23 | 2024-02-06 | Mesoblast Int Sarl | Método para tratar síndrome da dificuldade respiratória aguda (ards) com o uso de percursor de linhagem mesenquimal ou células-tronco |
| AU2022394471A1 (en) | 2021-11-17 | 2024-06-20 | Mesoblast International Sarl | Method of treating progressive heart failure in subjects at high risk of poor outcomes |
| US20250032552A1 (en) | 2021-12-23 | 2025-01-30 | Mesoblast International Sárl | Method of treating severe graft versus host disease |
| CA3257272A1 (en) | 2022-05-26 | 2023-11-30 | Mesoblast International Sàrl | HIGH FLOW FILTER AND METHOD OF USE |
| EP4536253A1 (en) | 2022-06-08 | 2025-04-16 | Mesoblast International Sàrl | Mesenchymal progenitor cells for enhancing partial reprogramming of target cells |
-
2021
- 2021-03-04 WO PCT/EP2021/055483 patent/WO2021176001A1/en not_active Ceased
- 2021-03-04 CA CA3170255A patent/CA3170255A1/en active Pending
- 2021-03-04 JP JP2022553155A patent/JP2023517035A/ja active Pending
- 2021-03-04 CN CN202180026562.1A patent/CN115361958A/zh active Pending
- 2021-03-04 EP EP21710902.4A patent/EP4114418B1/en active Active
- 2021-03-04 KR KR1020227033563A patent/KR20220150919A/ko active Pending
- 2021-03-04 BR BR112022017557A patent/BR112022017557A2/pt unknown
- 2021-03-04 US US17/905,742 patent/US12697355B2/en active Active
- 2021-03-04 AU AU2021232614A patent/AU2021232614A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120087933A1 (en) * | 2010-10-08 | 2012-04-12 | Samson Tom | Enhanced msc preparations |
| WO2015016761A2 (en) * | 2013-08-01 | 2015-02-05 | Isletone Ab | Mscs in the treatment of inflammatory pulmonary diseases |
| WO2018151046A1 (ja) * | 2017-02-15 | 2018-08-23 | ロート製薬株式会社 | 肺線維症治療剤、ptprr発現促進剤及び肺線維症治療用キット |
| WO2019051623A1 (es) * | 2017-09-16 | 2019-03-21 | Cells For Cells S.A. | Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos |
Non-Patent Citations (7)
| Title |
|---|
| BMC PUBLIC HEALTH, vol. Vol.20, Article number:6, JPN6024051413, January 2020 (2020-01-01), ISSN: 0005630920 * |
| CHEST, vol. 143, no. 6, JPN6024051409, 2013, pages 1590 - 1598, ISSN: 0005630918 * |
| ENGINEERING, vol. 6, JPN6024051411, February 2020 (2020-02-01), pages 1153 - 1161, ISSN: 0005833910 * |
| JOURNAL OF BIOMEDICAL SCIENCE, vol. Vol.23, Article number:76, JPN6024051412, 2016, ISSN: 0005630921 * |
| RESPIRATORY RESEARCH, vol. Vol.15, Article number:39, JPN6024051410, 2014, ISSN: 0005630922 * |
| STEM CELL RESEARCH & THERAPY, vol. 11, no. 60, JPN6025026160, 13 February 2020 (2020-02-13), pages 1 - 14, ISSN: 0005630917 * |
| 日本職業・災害医学会会誌, vol. 62, no. 3, JPN6024051414, 2014, pages 184 - 188, ISSN: 0005630919 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021232614A1 (en) | 2022-09-29 |
| BR112022017557A2 (pt) | 2022-12-27 |
| EP4114418A1 (en) | 2023-01-11 |
| CN115361958A (zh) | 2022-11-18 |
| EP4114418B1 (en) | 2026-05-20 |
| CA3170255A1 (en) | 2021-09-10 |
| US20230293589A1 (en) | 2023-09-21 |
| WO2021176001A1 (en) | 2021-09-10 |
| US12697355B2 (en) | 2026-08-04 |
| KR20220150919A (ko) | 2022-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI698242B (zh) | 利用血管母細胞產生間葉基質細胞之方法 | |
| US20090274665A1 (en) | Stem Cells For Treating Lung Diseases | |
| US20230293589A1 (en) | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells | |
| US20230165904A1 (en) | Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells | |
| JP2023513847A (ja) | 慢性移植片対宿主病の治療方法 | |
| JP2023517641A (ja) | 炎症性腸疾患を治療するための方法ii | |
| US20240197787A1 (en) | Method for treating acute respiratory distress syndrome (ards) in specific patients using mesenchymal lineage precursor or stem cells | |
| JP2023517636A (ja) | 炎症性腸疾患を治療するための方法i | |
| WO2023119239A1 (en) | Method of treating severe graft versus host disease | |
| KR20230119676A (ko) | 클래스 ii 심부전 환자의 진행성 심부전 치료 방법 | |
| WO2007019107A2 (en) | Adipose tissue stem cells, perivascular cells and pericytes | |
| CN117337184A (zh) | 使用间充质谱系前体细胞或干细胞治疗急性呼吸窘迫综合征(ards)的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240304 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240304 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20241218 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241223 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250324 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250701 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250925 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260407 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260807 |